News

In addition, the company announced that the FDA has granted expedited review status to the Alair system. Bronchial thermoplasty with the Alair system is an investigational procedure that

Under the terms of the agreement, Forma will leverage its transformative biology and chemistry platform to develop inhibitors for an undisclosed protein-protein interaction target in the field of

The two companies have formed a global platform for the introduction of the Sohm brand of generic medicines into the African, Latin American, and Southeast Asian markets. Generic

The clinical trial is an international, multi-center, placebo-controlled study that will examine the effectiveness of SLC022 in controlling pain associated with post-herpetic neuralgia (PHN). Solace anticipates having results

Under the terms of the agreement Abbott receives a non-exclusive license to MethylPlex for in vitro molecular diagnostics to detect the presence or risk of prostate, bladder and

In his new role, Mr Ros will lead the US sales and marketing strategy of Boehringer Ingelheim’s core brands. Mr Ros has been with Boehringer Ingelheim for 14

Prior to joining Stem Cell Therapeutics (SCT), Mr Herring was the president, CFO and director of Atlas Minerals. Prior thereto Mr Herring was the CFO of Velo Energy,

The board, after reviewing the proposal with its financial and legal advisors, has determined to reject the proposal. The company is actively pursuing a strategic alternative that the

From September 2001 to November 2008, Dr Llana held various positions of increasing responsibility at Biogen Idec, including most recently as the vice president of its oncology/rheumatology strategic